Wall Street slips as earnings season gets under way
NEW YORK (Reuters) - U.S. stocks fell on Tuesday, retreating from last week's rally on the "fiscal cliff" deal in Washington, as companies started to report results for the fourth quarter.
After a 4.3 percent jump in the two sessions around the close of the fiscal cliff negotiations, the S&P has declined a bit, with investors finding few catalysts to extend the rally that took the benchmark to five-year highs.
"We had a brief respite, courtesy of what happened on the fiscal cliff deal and the flip of the calendar with new money coming into the market," said Bucky Hellwig, senior vice president at BB&T Wealth Management in Birmingham, Alabama.
Shares of AT&T Inc (T.N) dropped 1.7 percent to $34.35, making it one of the biggest drags on the S&P 500, after the company said it sold more than 10 million smartphones in the quarter.
This figure beat the same quarter in 2011, but also means increased costs for the wireless service provider. Providers like AT&T pay hefty subsidies to handset makers so that they can offer discounts to customers who commit to two-year contracts.
Fourth-quarter profits are expected to beat the previous quarter's lackluster results, but analyst estimates are down sharply from October. Quarterly earnings are expected to grow by 2.7 percent, according to Thomson Reuters data. Dow component Alcoa, the largest U.S. aluminum producer, reported results after the closing bell.
The Dow Jones industrial average dropped 55.44 points, or 0.41 percent, to 13,328.85. The Standard & Poor's 500 Index fell 4.74 points, or 0.32 percent, to 1,457.15. The Nasdaq Composite Index lost 7.01 points, or 0.23 percent, to 3,091.81.
"The stark reality of uncertainty with regard to earnings, plus the negotiations on the debt ceiling, are there and that doesn't give investors a lot of reason to take bets on the long side," Hellwig said.
With AT&T's fall, the S&P telecom services index was the worst performer of the 10 major S&P sectors, down 2.7 p e rcent.
Sears Holdings (SHLD.O) shares dropped 6.4 percent to $40.16 a day after the company said Chairman Edward Lampert would take over as CEO from Louis D'Ambrosio, who is stepping down due to a family member's health issue. The U.S. retailer also reported a 1.8 percent decline in quarter-to-date sales at stores open at least a year.
Markets went lower as some of the first reported earnings were weak.
"It doesn't seem to be bouncing back, it might stay here or sell off a little further," said Stephen Carl, head of U.S. equity trading at The Williams Capital Group in New York.
Shares of restaurant-chain operator Yum Brands Inc (YUM.N) fell 4.2 percent to $65.04 a day after the KFC parent warned sales in China, its largest market, shrank more than expected in the fourth quarter.
GameStop (GME.N) was one of the worst performers on the S&P 500 as shares slumped 6.3 p ercent to $23.19 a fter the video game retailer reported low customer traffic for the holiday season and cut its guidance.
Shares of Monsanto Co (MON.N) gained 2.5 percent to $98.42 a fter reaching a more than four-year high at $99.99. The world's largest seed company raised its earnings outlook for fiscal year 2013 and posted strong first-quarter results.
Volume was below the 2012 average of 6.42 billion shares traded per day, as 6.19 billion were traded on the New York Stock Exchange, NYSE MKT and Nasdaq.
Declining stocks outnumbered advancing ones on the NYSE by 1,495 to 1,458, while on the Nasdaq decliners beat advancers 1,305 to 1,158.
(Reporting by Gabriel Debenedetti; Editing by Kenneth Barry and Nick Zieminski)
- Tweet this
- Share this
- Digg this
- Wal-Mart and allies in face-off with Apple Pay over mobile payments
- Hundreds of Iraqi tribesmen opposed to Islamic State found in mass graves
- India's universal healthcare rollout to cost $26 billion
- PM Modi boots officials out of the first class cabin
- Sensex, Nifty hit record highs, shrug off Fed's hawkish tone
India's universal health plan that aims to offer guaranteed benefits to a sixth of the world's population will cost an estimated 1.6 trillion rupees ($26 billion) over the next four years, a senior health ministry official said. Full Article